Surfactant Wash Buffer for CEX Viral Clearance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current protein purification processes, particularly for monoclonal antibodies, require multiple chromatography steps which reduce protein yield, increase costs, and complicate manufacturing due to limited viral clearance capabilities of cation exchange chromatography (CEX) as a standalone polishing step.

Innovation Solution

Incorporating a surfactant into the wash buffer during CEX chromatography enhances viral clearance, allowing for the removal of additional polishing steps like anion exchange chromatography, thereby simplifying the process and improving target product recovery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If multiple chromatography steps (ProA, CEX, AEX) are used for protein purification, then viral clearance and impurity removal are improved, but protein yield decreases and manufacturing complexity increases

Engineering Contradiction:
Improveviral clearanceVSAvoidprotein yield
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent combines viral clearance function into the CEX chromatography step by using a surfactant-containing wash buffer, merging the previously separate functions of CEX (impurity removal) and AEX (viral clearance) into a single step, thereby reducing the number of chromatography steps while maintaining both impurity removal and viral clearance capabilities

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The CEX chromatography step is enhanced to perform multiple functions simultaneously: removing host cell proteins, DNA, aggregates, and clearing viruses, making it a multi-functional step that replaces what were previously separate polishing steps

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If multiple chromatography steps are used for protein purification, then viral clearance and impurity removal are improved, but manufacturing complexity increases

Engineering Contradiction:
Improveviral clearanceVSAvoidmanufacturing complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple chromatography steps into a single CEX step by adding surfactant to the wash buffer, combining viral clearance and impurity removal functions into one operation, thereby reducing manufacturing complexity while maintaining reliability

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The enhanced CEX step serves as a universal polishing step that performs multiple functions (HCP removal, DNA removal, aggregate removal, and viral clearance) that were previously distributed across multiple separate steps, simplifying the overall manufacturing process

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Device complexity

If CEX is used as the only polishing step, then manufacturing complexity is reduced, but viral clearance capability is insufficient

Engineering Contradiction:
Improvemanufacturing complexityVSAvoidviral clearance
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent changes the chemical composition parameter of the CEX wash buffer by adding surfactant, which fundamentally alters the viral clearance capability of the CEX step, enabling it to achieve adequate viral clearance while maintaining simplicity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Surfactant acts as an intermediary substance in the CEX wash buffer that mediates the interaction between the chromatography support and viruses, enhancing viral clearance capability without requiring additional chromatography steps

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The surfactant-enhanced CEX process achieves effective viral clearance without compromising impurity removal, enabling the reduction of chromatography steps and manufacturing complexity, and maintaining protein yield.

Implementation Method 1

The application of the wash procedure, and its associated robust viral clearance capability, can enable the removal of certain other polishing chromatography steps, such as AEX, resulting in reduced number of chromatography steps needed.

Methodology Applied
Scientific EffectSurfactant: Surfactant

Implementation Method 2

Cation exchange (CEX) for DNA, HCP and aggregate removal

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Implementation Method 3

Protein A (ProA) for product recovery and host cell protein (HCP) removal

Methodology Applied
Scientific EffectAffinity chromatography: Adsorption

Data Source

PatentUS11426706B2Cation exchange chromatography wash buffer
Publication Date: 2022.08.30 CEPHALON INC
  • US11426706B2 patent drawing

AI summary

A wash buffer comprising a surfactant for use in affinity and cation exchange chromatography to purify proteins of interest from protein aggregates and to remove and/or inactivate viruses. When used during affinity or cation exchange chromatography for the purification of a protein of interest, such as an antibody, the wash buffer significantly improves viral clearance from the preparation, while also reducing the levels of host cell proteins and protein aggregates. Following affinity or cation exchange chromatography with the wash buffer, the protein of interest may be further purified using other chromatography and filtration operations.